Clinical Epigenetics · 2022 · 40 citations · 5 references
Life SciencesGeneticsMolecular BiologyEpigeneticsEpigenomicsGenomicsDna MethylationDna Methylation ProfilingEpigenetic AlterationsEpigenetic Biomarker DiscoveryEpigenetic BiomarkersEpigenomic ProfilingAngiotensin Receptor SignalingDisease-specific Methylation SignaturesDna Methylation BiomarkersEpigenetic Signature DiscoveryEpigenomic SignaturesGenome-wide Methylation AnalysisGenome-wide Methylation ProfilingMuscarinic Acetylcholine Receptor Signaling
Post-acute COVID-19 syndrome (PACS) has been defined as symptoms persisting after clearance of a COVID-19 infection. We have previously demonstrated that alterations in DNA methylation (DNAm) status persist in individuals who recovered from a COVID-19 infection, but it is currently unknown if PACS is associated with epigenetic changes. We compared DNAm patterns in patients with PACS with those in controls and in healthy COVID-19 convalescents and found a unique DNAm signature in PACS patients. This signature unravelled modified pathways that regulate angiotensin II and muscarinic receptor signalling and protein-protein interaction networks that have bearings on vesicle formation and mitochondrial function.
5
Blood DNA methylation and COVID-19 outcomes
Joseph Balnis, Andy Madrid, Kirk J. Hogan et al. · Clinical Epigenetics · 2021 · 128 citations · Full text